Microtech 2011

Label-free Cardiomyocyte Enrichment in Microfabricated Device

A. Hsieh, A. Sofla, M. Radisic
University of Toronto, CA

Keywords: Cardiac Tissue Engineering, Microfluidics, Cell Separation


Cardiomyocyte (CM) is the functional conducing cells among fibroblast and endothelial in the myocardium. Myocardial infarction results in cell death and scar formation, compromise heart function, and eventually lead to heart enlargement, and death. Cardiomyocyte sources, being derived from embryonic and induced pluripotent cells with their virtually unlimited sources due to its self-renewal and directed differentiation capacity, serve as promising resources for cardiac tissue engineering applications. With CM surface markers still unknown, intracellular labelling requires cell permeabilization and results in no viable cell, impeding translational studies. Herein, we developed a microfluidic chip integrated with magnetic field at 0.5T to efficiently isolate CMs from heterogeneous cell populations. Cell viability and functionality were preserved up to 50mM oxidant treatment (CFDA/PI, ET = 4.6 V/cm, MCR = 8.2 Hz). Target protein in CM was identified in the absorption spectra at the soret band of 400nm as reported in the literature. Elisa quantification showed the developmental increase of the target protein from neonatal to adult rat (0.11 and 0.73 ×10-14 mole/cell, respectively). Maintenance of CM morphology was studied with comparable anti-cardiac troponin T staining. With the current concentrator outside the channel prototype, CM population was enriched through the magnetic microfluidic device compared to non-treated samples by 30% shown by FACS.

TechConnect World 2011 Nanotech 2011 Clean Technology 2011 Microtech 2011 BioNanotech 2011 TechConnect Summit 2011
Program | Symposia | Exhibition | Press | Venue | Register |
Short Courses | News | Subscribe | Contact | Site Map
© Copyright 2010 TechConnect World. All Rights Reserved.